Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 502971487

Cayman Chemical 4AmInobenzoIc ACD hydrazID
SDP

Supplier:  Cayman Chemical 14845500 MG

Encompass_Preferred

A prodrug form of remogliflozin A inhibits human SGLT2 and SGLT1 (Kis 1.95 and 43.1 M respectively) inhibits increases in plasma glucose levels in a glucose tolerance test in a rat model of STZ-induced diabetes at 3 and 10 mg/ml increases fasting plasma insulin levels and reduces fasting plasma glucose and triglyceride levels as well as urinary glucose excretion in a db/db mouse model of diabetes with hyperinsulinemia and obesity at 10 and 30 mg/kg twice per day for 6 weeks

Catalog No. 50-297-1487


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.